Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma

NCT00602641 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

306

Enrollment

NIH

Sponsor class

Conditions

Multiple Myeloma

Interventions

OTHER: Laboratory Biomarker Analysis
DRUG: Lenalidomide
DRUG: Melphalan
DRUG: Prednisone
OTHER: Quality-of-Life Assessment
DRUG: Thalidomide

Sponsor

National Cancer Institute (NCI)